Current status of immunotoxins application in cancer patient’s treatment

Cancer is known as one of the most common causes of death in the world and the number of patients is increasing every year. Cancer is a major cause of death in the world.

Due to the problems of using conventional methods of chemotherapy and radiation therapy, including the resistance of cancer cells to some chemotherapy drugs and having side effects and toxicity of these drugs on healthy tissues, it seems necessary to provide new solutions for specific and more effective cancer treatment. Immune glubloin-based treatments have become particularly crucial in the treatment of cancer. Today, the use of recombinant proteins that can track, identify and destroy specific tissues and cells is of interest to researchers.

The result of the research was the discovery of a type of intelligent hybrid proteins called immunotoxins.

In this study we provided a review of the biological and clinical applications of immunotoxins in treatment of cancer. immunotoxins indicated that can act against cancer tissues. Immunotoxins might be effective in removing circulating tumor cells with large amounts of antigens.